Cargando…
Kanamycin and Cisplatin Ototoxicity: Differences in Patterns of Oxidative Stress, Antioxidant Enzyme Expression and Hair Cell Loss in the Cochlea
Kanamycin and cisplatin are ototoxic drugs. The mechanisms are incompletely known. With subcutaneous kanamycin (400 mg/kg, 15 days), auditory threshold shifts were detected at days 12–13 at 16 and 32 kHz, extending to 8 and 4 kHz at days 14–15. The outer hair cell (OHC) loss was concentrated past da...
Autores principales: | Gibaja, Alejandro, Alvarado, Juan C., Scheper, Verena, Carles, Liliana, Juiz, José M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495324/ https://www.ncbi.nlm.nih.gov/pubmed/36139833 http://dx.doi.org/10.3390/antiox11091759 |
Ejemplares similares
-
Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats
por: Lee, Chang Ho, et al.
Publicado: (2021) -
Opa1 Prevents Apoptosis and Cisplatin-Induced Ototoxicity in Murine Cochleae
por: Dong, Tingting, et al.
Publicado: (2021) -
Mechanism of alpha-lipoic acid in attenuating kanamycin-induced ototoxicity☆
por: Wang, Aimei, et al.
Publicado: (2012) -
Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
por: Mantefardo, Bahru, et al.
Publicado: (2021) -
Ephrin A2 protein expression in the regeneration and plasticity of cochlear hair cells in chicken following kanamycin ototoxicity★
por: Yu, Jia, et al.
Publicado: (2012)